Article navigation

Automation of cell culture techniques and drug discovery programmes in the life science industries is increasing as pharmaceutical and biotech companies realise the advantages achievable through the use of multi‐axis robots bringing precise control and reliable, consistent performance to many complex and delicate processes. Describes the development and application of the “Cellmate” and “SelecT” robotic cell culture and drug discovery systems by the UK company The Automation Partnership Ltd.. Benefits sited include flexibility of operation and smooth movements that are essential for handling fragile cell cultures.

You do not currently have access to this content.
Don't already have an account? Register

Purchased this content as a guest? Enter your email address to restore access.

Pay-Per-View Access
$41.00
Rental

or Create an Account

Close subscription notice
Close access options